English
简体中文
Total: £ 56.28
Published Date: 2025-09-18 | Pages: 73 | Tables: 65 | Pharma & Healthcare
The global Prothrombin Complex Concentrate (PCC) Drug market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Prothrombin Complex Concentrate (PCC) Drug market competitiveness, regional economic performance, and supply chain configurations.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
In Europe and United States market, key players of prothrombin complex concentrate (PCC) drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. The top one player hold a share about 58%. United States is the largest market, has a share about 47%, followed by Germany, and France, with share 13% and 12%, separately.
The global Prothrombin Complex Concentrate (PCC) Drug market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
By Type: (Dominant Segment vs High-Margin Innovation)
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Hemophilia B
Acquired Coagulation Factor Deficiency
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., CSL Behring in Europe)
- Emerging Product Trends: Beriplex adoption vs. Profilnine premiumization
- Demand-Side Dynamics: Hemophilia B growth in China vs. Acquired Coagulation Factor Deficiency potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Prothrombin Complex Concentrate (PCC) Drug market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Profilnine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Acquired Coagulation Factor Deficiency in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Beriplex dominance in Europe vs. Profilnine demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Prothrombin Complex Concentrate (PCC) Drug Product Scope
1.2 Prothrombin Complex Concentrate (PCC) Drug by Type
1.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2020 & 2024 & 2031)
1.2.2 Beriplex
1.2.3 Profilnine
1.2.4 Octaplex
1.2.5 Prothromplex
1.2.6 Cofact
1.2.7 Other
1.3 Prothrombin Complex Concentrate (PCC) Drug by Application
1.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hemophilia B
1.3.3 Acquired Coagulation Factor Deficiency
1.4 Global Prothrombin Complex Concentrate (PCC) Drug Market Estimates and Forecasts (2020-2031)
1.4.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Prothrombin Complex Concentrate (PCC) Drug Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Prothrombin Complex Concentrate (PCC) Drug Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2020-2025)
2.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2020-2025)
2.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Prothrombin Complex Concentrate (PCC) Drug Market Size and Prospective (2020-2031)
2.4.2 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size and Prospective (2020-2031)
2.4.3 China Prothrombin Complex Concentrate (PCC) Drug Market Size and Prospective (2020-2031)
2.4.4 Japan Prothrombin Complex Concentrate (PCC) Drug Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Prothrombin Complex Concentrate (PCC) Drug Historic Market Review by Type (2020-2025)
3.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2020-2025)
3.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2020-2025)
3.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (2020-2025)
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Type (2026-2031)
3.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Type (2026-2031)
3.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Type (2026-2031)
3.3 Different Types Prothrombin Complex Concentrate (PCC) Drug Representative Players
4 Global Market Size by Application
4.1 Global Prothrombin Complex Concentrate (PCC) Drug Historic Market Review by Application (2020-2025)
4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2020-2025)
4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2020-2025)
4.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Application (2020-2025)
4.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Application (2026-2031)
4.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Application (2026-2031)
4.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Prothrombin Complex Concentrate (PCC) Drug Application
5 Competition Landscape by Players
5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Players (2020-2025)
5.2 Global Top Prothrombin Complex Concentrate (PCC) Drug Players by Revenue (2020-2025)
5.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate (PCC) Drug as of 2024)
5.4 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Type & Application
5.7 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Company
6.1.1.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2025)
6.1.1.2 North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2025)
6.1.2 North America Prothrombin Complex Concentrate (PCC) Drug Sales Breakdown by Type (2020-2025)
6.1.3 North America Prothrombin Complex Concentrate (PCC) Drug Sales Breakdown by Application (2020-2025)
6.1.4 North America Prothrombin Complex Concentrate (PCC) Drug Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Company
6.2.1.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2025)
6.2.1.2 Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2025)
6.2.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Breakdown by Type (2020-2025)
6.2.3 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Breakdown by Application (2020-2025)
6.2.4 Europe Prothrombin Complex Concentrate (PCC) Drug Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Prothrombin Complex Concentrate (PCC) Drug Sales by Company
6.3.1.1 China Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2025)
6.3.1.2 China Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2025)
6.3.2 China Prothrombin Complex Concentrate (PCC) Drug Sales Breakdown by Type (2020-2025)
6.3.3 China Prothrombin Complex Concentrate (PCC) Drug Sales Breakdown by Application (2020-2025)
6.3.4 China Prothrombin Complex Concentrate (PCC) Drug Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Prothrombin Complex Concentrate (PCC) Drug Sales by Company
6.4.1.1 Japan Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2025)
6.4.1.2 Japan Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2025)
6.4.2 Japan Prothrombin Complex Concentrate (PCC) Drug Sales Breakdown by Type (2020-2025)
6.4.3 Japan Prothrombin Complex Concentrate (PCC) Drug Sales Breakdown by Application (2020-2025)
6.4.4 Japan Prothrombin Complex Concentrate (PCC) Drug Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 CSL Behring
7.1.1 CSL Behring Company Information
7.1.2 CSL Behring Business Overview
7.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
7.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Products Offered
7.1.5 CSL Behring Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Business Overview
7.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Products Offered
7.2.5 Grifols Recent Development
7.3 Octapharma
7.3.1 Octapharma Company Information
7.3.2 Octapharma Business Overview
7.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Products Offered
7.3.5 Octapharma Recent Development
7.4 Prothya Biosolutions
7.4.1 Prothya Biosolutions Company Information
7.4.2 Prothya Biosolutions Business Overview
7.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Products Offered
7.4.5 Prothya Biosolutions Recent Development
7.5 Takeda
7.5.1 Takeda Company Information
7.5.2 Takeda Business Overview
7.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Products Offered
7.5.5 Takeda Recent Development
8 Prothrombin Complex Concentrate (PCC) Drug Manufacturing Cost Analysis
8.1 Prothrombin Complex Concentrate (PCC) Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug
8.4 Prothrombin Complex Concentrate (PCC) Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Prothrombin Complex Concentrate (PCC) Drug Distributors List
9.3 Prothrombin Complex Concentrate (PCC) Drug Customers
10 Prothrombin Complex Concentrate (PCC) Drug Market Dynamics
10.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends
10.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
10.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges
10.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Prothrombin Complex Concentrate (PCC) Drug Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Prothrombin Complex Concentrate (PCC) Drug Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Prothrombin Complex Concentrate (PCC) Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Region (2020-2025)
Table 5. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2020-2025)
Table 6. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Region (2020-2025)
Table 8. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share Forecast by Region (2026-2031)
Table 12. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (K Units) & (2020-2025)
Table 13. Global Prothrombin Complex Concentrate (PCC) Drug Sales Share by Type (2020-2025)
Table 14. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (K Units) & (2026-2031)
Table 17. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (K Units) & (2020-2025)
Table 21. Global Prothrombin Complex Concentrate (PCC) Drug Sales Share by Application (2020-2025)
Table 22. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Prothrombin Complex Concentrate (PCC) Drug Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (K Units) & (2026-2031)
Table 25. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Prothrombin Complex Concentrate (PCC) Drug Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Prothrombin Complex Concentrate (PCC) Drug Application
Table 28. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Company (K Units) & (2020-2025)
Table 29. Global Prothrombin Complex Concentrate (PCC) Drug Sales Share by Company (2020-2025)
Table 30. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Company (2020-2025)
Table 32. Global Prothrombin Complex Concentrate (PCC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate (PCC) Drug as of 2024)
Table 33. Global Market Prothrombin Complex Concentrate (PCC) Drug Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Type & Application
Table 36. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2025) & (K Units)
Table 39. North America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Company (2020-2025)
Table 40. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company (2020-2025)
Table 42. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2020-2025) & (K Units)
Table 43. North America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2025)
Table 44. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2020-2025) & (K Units)
Table 45. North America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2025)
Table 46. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2025) & (K Units)
Table 47. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Company (2020-2025)
Table 48. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company (2020-2025)
Table 50. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2020-2025) & (K Units)
Table 51. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2025)
Table 52. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2020-2025) & (K Units)
Table 53. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2025)
Table 54. China Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2025) & (K Units)
Table 55. China Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Company (2020-2025)
Table 56. China Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company (2020-2025)
Table 58. China Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2020-2025) & (K Units)
Table 59. China Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2025)
Table 60. China Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2020-2025) & (K Units)
Table 61. China Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2025)
Table 62. Japan Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2025) & (K Units)
Table 63. Japan Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Company (2020-2025)
Table 64. Japan Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company (2020-2025)
Table 66. Japan Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2020-2025) & (K Units)
Table 67. Japan Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2025)
Table 68. Japan Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2020-2025) & (K Units)
Table 69. Japan Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2025)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product
Table 74. CSL Behring Recent Development
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Grifols Prothrombin Complex Concentrate (PCC) Drug Product
Table 79. Grifols Recent Development
Table 80. Octapharma Company Information
Table 81. Octapharma Description and Business Overview
Table 82. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product
Table 84. Octapharma Recent Development
Table 85. Prothya Biosolutions Company Information
Table 86. Prothya Biosolutions Description and Business Overview
Table 87. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product
Table 89. Prothya Biosolutions Recent Development
Table 90. Takeda Company Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Takeda Prothrombin Complex Concentrate (PCC) Drug Product
Table 94. Takeda Recent Development
Table 95. Production Base and Market Concentration Rate of Raw Material
Table 96. Key Suppliers of Raw Materials
Table 97. Prothrombin Complex Concentrate (PCC) Drug Distributors List
Table 98. Prothrombin Complex Concentrate (PCC) Drug Customers List
Table 99. Prothrombin Complex Concentrate (PCC) Drug Market Trends
Table 100. Prothrombin Complex Concentrate (PCC) Drug Market Drivers
Table 101. Prothrombin Complex Concentrate (PCC) Drug Market Challenges
Table 102. Prothrombin Complex Concentrate (PCC) Drug Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Prothrombin Complex Concentrate (PCC) Drug Product Picture
Figure 2. Global Prothrombin Complex Concentrate (PCC) Drug Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Beriplex Product Picture
Figure 5. Profilnine Product Picture
Figure 6. Octaplex Product Picture
Figure 7. Prothromplex Product Picture
Figure 8. Cofact Product Picture
Figure 9. Other Product Picture
Figure 10. Global Prothrombin Complex Concentrate (PCC) Drug Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 11. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application in 2024 & 2031
Figure 12. Hemophilia B Examples
Figure 13. Acquired Coagulation Factor Deficiency Examples
Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate (2020-2031) & (US$ Million)
Figure 16. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) Growth Rate (2020-2031)
Figure 17. Global Prothrombin Complex Concentrate (PCC) Drug Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 18. Prothrombin Complex Concentrate (PCC) Drug Report Years Considered
Figure 19. Global Market Prothrombin Complex Concentrate (PCC) Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 20. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region: 2020 VS 2024
Figure 21. North America Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) Growth Rate (2020-2031)
Figure 23. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Europe Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) Growth Rate (2020-2031)
Figure 25. China Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. China Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) Growth Rate (2020-2031)
Figure 27. Japan Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) Growth Rate (2020-2031)
Figure 29. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Type (2020-2025)
Figure 30. Global Prothrombin Complex Concentrate (PCC) Drug Sales Share by Type (2026-2031)
Figure 31. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Type (2026-2031)
Figure 32. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Application (2020-2025)
Figure 33. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate by Application in 2020 & 2024
Figure 34. Global Prothrombin Complex Concentrate (PCC) Drug Sales Share by Application (2026-2031)
Figure 35. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Application (2026-2031)
Figure 36. Global Prothrombin Complex Concentrate (PCC) Drug Sales Share by Company (2024)
Figure 37. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Company (2024)
Figure 38. Global 5 Largest Prothrombin Complex Concentrate (PCC) Drug Players Market Share by Revenue in Prothrombin Complex Concentrate (PCC) Drug: 2020 & 2024
Figure 39. Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 40. Manufacturing Cost Structure of Prothrombin Complex Concentrate (PCC) Drug
Figure 41. Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug
Figure 42. Prothrombin Complex Concentrate (PCC) Drug Industrial Chain
Figure 43. Channels of Distribution (Direct Vs Distribution)
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
